Friday , August 19 2022

Pay attention to the lack of Spanish WHO drug supply



[ad_1]

The Spanish Agency for Medicines and Health Products (Aemps) has reported on the the shortage of the drug Konakion (fitomenadiona), from the German laboratory Cheplapharm Arzneimittel.

It may seem an incredible medication as it is noted for something that is not well known by the general public, namely the hypoprothrombinemia and bleeding of newborn due to lack of vitamin K, but it is a drug considered essential by the World Health Organization (WHO), because this is the only specific anti-user service available for overdose with vitamin K anticoagulants

The active substance is phytomenadione and it is also noted for the overuse of anti-bullying drugs that derive from itor coumarin, like the well known Sintrom and treat the vitamin deficiency k.

The positive part is that the Aemps have already established the mechanisms to solve this situation, which is included for exporting these medicines to third countries – if there were two listed distributions -, to search for foreign medicines of the same composition in different countries – they already have units of three suppliers Different – and link to all distribution entities in which these medicines have been distributed in recent months, to obtain information about the units available and to transfer to the local representative, so that Distribute to the hospitals that are needed.

Therefore, they are expected to be available from next week adult delivery unitss through the Overseas Medicines Service, although there is no quick solution to the problem supply for the drug pediatric version.

The authorized medicines in Spain containing fitomenadione are two: Konakion 2mg / 0.2 ml pediatric oral answer / solution for injection, 5 ml of 0.2 ml and Konakion 10 mg / ml oral solution / solution for injection, in formats of 5 amp and 1 ml amp and 1 ml amp.

The laboratory is the authorization holder of both medications Cheplapharm Arzneimittel GmbH, with a registered office in Germany, and a local representative in Spain is Ruby Labs, which informed the AEMPS of product absence due to the interruption of supply from the owner.

[ad_2]
Source link